ARCHIVES

Study Finds More Deaths On Aranesp Arm In Cancer Anemia Study, No Benefit Seen.

This article is from The Cancer Letter archive.

Vol. 33 No. 04 | February 2, 2007

Download PDF Visit The Full Archive

Related Articles

FDA Faces Severe Regulatory, Scientific Needs, Report Finds.

February 1, 2008

NCI Says Review Group Will Read Blueprint, Evaluate NCI Research

January 16, 1998

Proof of principle needed before launching “big science” program, advisors say.

March 11, 2005

FDA News: Zydelig approved in three B-cell blood cancers

August 1, 2014

NIH Priority To Pay 4,000 Grants, Send Summary Statements

February 2, 1996

Grossman Leads Neuro-Oncology Society; NYU Recruits Radiation Oncology Director.

January 14, 2000